Table 1.
Trial | Condition | Treatment | Target sample size rangea | Number of active UK sites (at time of writing)a | Timing of trial opening to recruitmentb | ||
---|---|---|---|---|---|---|---|
1 | Renal | Dialysis | 300–400 | 1–10 | During pandemic | ||
2 | Renal | Dialysis | 500–600 | 20–30 | Pre-pandemic | ||
3 | Oncology | Surgery | None | 10–20 | During pandemic | ||
4 | Neurosurgery | Surgery | 200–300 | 1–10 | During pandemic | ||
5 | Orthopaedics | Surgery | 400–500 | 10–20 | Post-restrictions | ||
6 | Neurosurgery | Surgery | 50–100 | 20–30 | During pandemic | ||
7 | Orthopaedics | Surgery | 300–400 | 1–10 | During pandemic | ||
8 | Urology | Surgery | 200–300 | 10–20 | Pre-pandemic | ||
9 | Oncology | Surgery | 750–1000 | 50–100 | Pre-pandemic | ||
10 | Oncology | Chemotherapy | 4000–5000 | 100 + | Pre-pandemic | ||
11 | Hepatobiliary | Surgery | 5000 + | 50–100 | Pre-pandemic | ||
12 | Mental health | Medication | 300–400 | 10–20 | During pandemic | ||
13 | Surgery | Others | 2000–3000 | 1–10 | Pre-pandemic |
aWe have not given precise numbers as this would potentially identify trials
bPandemic defined as from March 2020 to February 2022 when all legal UK restrictions were lifted